{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:03:23Z","timestamp":1788476603344,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Artificial intelligence (AI) can play a vital role in achieving a shift towards predictive, preventive, and personalized medicine, provided we are guided by the science with and of patient input. Patient-reported outcome measures (PROMs) represent a unique opportunity to capture experiential knowledge from people living with health conditions and make it scientifically relevant for all other stakeholders. Despite this, there is limited uptake of the use of standardized outcomes including PROMs within the research and healthcare system. This perspective article discusses the challenges of using PROMs at scale, with a focus on multiple sclerosis. AI approaches can enable learning health systems that improve the quality of care by examining the care health systems presently give, as well as accelerating research and innovation. However, we argue that it is crucial that advances in AI \u2013 whether relating to research, clinical practice or health systems policy \u2013 are not developed in isolation and implemented \u2018to\u2019 people, but in collaboration \u2018with\u2019 them. This implementation of science with patient input, which is at the heart of the Global PROs for Multiple Sclerosis (PROMS) Initiative, will ensure that we maximize the potential benefits of AI for people with MS, whilst avoiding unintended consequences.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1487709","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T05:11:50Z","timestamp":1739769110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Artificial intelligence and science of patient input: a perspective from people with multiple sclerosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Anne","family":"Helme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Brichetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Peryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Vermersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Weiland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Zaratin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckac103","article-title":"An overview of Personalized Medicine landscape and policies in the European Union","volume":"32","author":"Beccia","year":"2022","journal-title":"Eur J Public Health"},{"key":"B2","unstructured":"EU4Health programme 2021-2027 \u2013 a vision for a healthier European Union - European Commission\n          \n          \n          2024"},{"key":"B3","unstructured":"Number of people with MS | Atlas of MS"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2196\/humanfactors.5919","article-title":"Integrating patient-generated health data into clinical care settings or clinical decision-making: lessons learned from project healthDesign","volume":"3","author":"Cohen","year":"2016","journal-title":"JMIR Hum Factors"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1407257\/full","article-title":"The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care \u2013 updates at the 2023 plenary event","volume":"15","author":"Zaratin","year":"2024","journal-title":"Front Neurol"},{"key":"B6","volume-title":"Defining value in \u2018value-based healthcare\u2019 \u2013 Report of the Expert Panel on Effective Ways of Investing in Health (EXPH)","year":"2019"},{"key":"B7","volume-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims","year":"2009"},{"key":"B8","unstructured":"Draft reflection paper on the use of patient reported outcome (PRO) measures in oncology studies\n          \n          \n          \n          2014"},{"key":"B9","unstructured":"Patient reported outcome for multiple sclerosis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"103757","DOI":"10.1016\/j.msard.2022.103757","article-title":"The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions","volume":"61","author":"Zaratin","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"B11","doi-asserted-by":"publisher","first-page":"20552173221105642","DOI":"10.1177\/20552173221105642","article-title":"Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables","volume":"8","author":"Bharadia","year":"2022","journal-title":"Mult Scler J - Exp Transl Clin"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02224-8","article-title":"Patient wisdom should be incorporated into health AI to avoid algorithmic paternalism","volume":"29","author":"McCradden","year":"2023","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"105376","DOI":"10.1016\/j.ijmedinf.2024.105376","article-title":"Use of wearables among Multiple Sclerosis patients and healthcare Professionals: A scoping review","volume":"184","author":"Alsulami","year":"2024","journal-title":"Int J Med Inf"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fresc.2021.737384\/full","article-title":"Validity and acceptability of wearable devices for monitoring step-count and activity minutes among people with multiple sclerosis","volume":"2","author":"Lavelle","year":"2022","journal-title":"Front Rehabil Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s41687-024-00711-1","article-title":"The challenge of using patient reported outcome measures in clinical practice: how do we get there","volume":"8","author":"Cella","year":"2024","journal-title":"J Patient-Rep Outcomes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.5.962","article-title":"The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure","volume":"124","author":"Hobart","year":"2001","journal-title":"Brain J Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF02260859","article-title":"A health-related quality of life measure for multiple sclerosis","volume":"4","author":"Vickrey","year":"1995","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"B18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2377-13-37","article-title":"Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis","volume":"13","author":"Learmonth","year":"2013","journal-title":"BMC Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/23279095.2015.1125905","article-title":"SymptoMScreen: A tool for rapid assessment of symptom severity in MS across multiple domains","volume":"24","author":"Green","year":"2017","journal-title":"Appl Neuropsychol Adult"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1511701","article-title":"Standardizing patient outcomes measurement","volume":"374","author":"Porter","year":"2016","journal-title":"N Engl J Med"},{"key":"B21","unstructured":"International consortium for health outcomes measurement"},{"key":"B22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1477-7525-11-210","article-title":"The case for an international patient-reported outcomes measurement information system (PROMIS\u00ae) initiative","volume":"11","author":"Alonso","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"B23","unstructured":"COMET initiative | Home"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000821","article-title":"Measuring outcomes that matter most to people with multiple sclerosis: the role of patient-reported outcomes","volume":"33","author":"Brichetto","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241269220","article-title":"Frequency and impact of symptoms experienced by people with MS - Results from the global PROMS Initiative survey","volume":"30","author":"Brichetto","year":"2024","journal-title":"ECTRIMS 2024 Late Breaking Poster. P891\/4083."},{"key":"B26","volume-title":"Tackling Wasteful Spending on Health","year":"2017"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2013-002524","article-title":"The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: a systematic review of qualitative research","volume":"23","author":"Boyce","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"B28","unstructured":"Alameda project"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.3390\/healthcare11192656","article-title":"Monitoring and predicting health status in neurological patients: the ALAMEDA data collection protocol","volume":"11","author":"Sorici","year":"2023","journal-title":"Healthc Basel Switz"},{"key":"B30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12961-022-00825-2","article-title":"The MULTI-ACT model: the path forward for participatory and anticipatory governance in health research and care","volume":"20","author":"Zaratin","year":"2022","journal-title":"Health Res Policy Syst"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(22)00252-7","article-title":"Embedding patient-reported outcomes at the heart of artificial intelligence health-care technologies","volume":"5","author":"Rivera","year":"2023","journal-title":"Lancet Digit Health"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12220-8","article-title":"Artificial intelligence in neurology: opportunities, challenges, and policy implications","volume":"271","author":"Voigtlaender","year":"2024","journal-title":"J Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s41687-024-00808-7","article-title":"Machine learning models including patient-reported outcome data in oncology: a systematic literature review and analysis of their reporting quality","volume":"8","author":"Krepper","year":"2024","journal-title":"J Patient-Rep Outcomes"},{"key":"B34","doi-asserted-by":"publisher","first-page":"100026","DOI":"10.1016\/j.esmorw.2024.100026","article-title":"Impact of artificial intelligence in transforming the doctor\u2013cancer patient relationship","volume":"3","author":"Heudel","year":"2024","journal-title":"ESMO Real World Data Digit Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1446748\/full","article-title":"A future of AI-driven personalized care for people with multiple sclerosis","volume":"15","author":"Praet","year":"2024","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241277376","article-title":"Integrating large language models in care, research, and education in multiple sclerosis management","volume":"30","author":"Inojosa","year":"2024","journal-title":"Mult Scler J"},{"key":"B37","unstructured":"ISO 27269:2021"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamaneurol.2024.3533","article-title":"Digital biomarkers for neurodegenerative disease","volume":"82","author":"Erickson","year":"2025","journal-title":"JAMA Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"103358","DOI":"10.1016\/j.ebiom.2021.103358","article-title":"Ensuring that biomedical AI benefits diverse populations","volume":"67","author":"Zou","year":"2021","journal-title":"eBioMedicine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2401.05654","article-title":"Towards conversational diagnostic AI","author":"Tu","year":"2024","journal-title":"arXiv"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12328-x","article-title":"ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis","volume":"271","author":"Maida","year":"2024","journal-title":"J Neurol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/jme-2022-108447","article-title":"Evidence, ethics and the promise of artificial intelligence in psychiatry","volume":"49","author":"McCradden","year":"2023","journal-title":"J Med Ethics"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(22)00249-7","article-title":"The role of patient-reported outcome measures in trials of artificial intelligence health technologies: a systematic evaluation of ClinicalTrials.gov records (1997\u20132022)","volume":"5","author":"Pearce","year":"2023","journal-title":"Lancet Digit Health"},{"key":"B44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12992-020-00584-1","article-title":"Artificial intelligence in health care: laying the Foundation for Responsible, sustainable, and inclusive innovation in low- and middle-income countries","volume":"16","author":"Alami","year":"2020","journal-title":"Glob Health"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002778","article-title":"Global health in the age of AI: Safeguarding humanity through collaboration and action","volume":"4","author":"Guzm\u00e1n","year":"2024","journal-title":"PloS Glob Public Health"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(20)30317-4","article-title":"Health data poverty: an assailable barrier to equitable digital health care","volume":"3","author":"Ibrahim","year":"2021","journal-title":"Lancet Digit Health"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocy052","article-title":"Good intentions are not enough: how informatics interventions can worsen inequality","volume":"25","author":"Veinot","year":"2018","journal-title":"J Am Med Inform Assoc JAMIA"},{"key":"B48","volume-title":"Ethics and governance of artificial intelligence for health: guidance on large multi-modal models","year":"2024"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1487709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T05:11:56Z","timestamp":1739769116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1487709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2025.1487709"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1487709","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"article-number":"1487709"}}